7th Circ. Won't Revive Payors' Depakote Suit Against Abbott
The Seventh Circuit declined Thursday to revive a proposed class action filed by welfare-benefit plans that claim they were ripped off when Abbott Laboratories Inc. illegally marketed its epilepsy drug Depakote...To view the full article, register now.
Already a subscriber? Click here to view full article